Dr. O’Brien was recognized for the over one hundred trials where she was the principal investigator and the over 900 publications that have changed for the better how CLL / SLL is managed.
I will soon be rescanned to see if my total of seven doses, with the last three being the full therapeutic dose of 48 mg of epcoritamab, has shrunken my lymph nodes.
Despite mild persistent night sweats and disturbed sleep, I am enjoying and learning much at iwCLL (international workshop on CLL) in Boston.
With all the new therapies, CLL management has radically changed for the better, and I have been the beneficiary repeatedly.
After seven weeks of cytokine release (CRS) and way too many steroids, I have finally gone almost four days with no fever without the antipyretic benefits of Tylenol or steroids
Dr. Brian Koffman spoke with Dr. Gregory Plotnikoff, a physician specializing in complex, chronic, mysterious illnesses. They discussed the role of diet and nutrition in CLL.
The survey has revealed gaps in support service provision in many countries and has emphasized and allowed the building online of a free global directory of patient-facing CLL resources.
BTK is a good therapeutic target in CLL because it is only critical for the function of B-cells, and thus loss of BTK is not lethal for the patient.
In those over 80 with chronic lymphocytic leukemia (CLL), older age and not being treated with a novel agent frontline were associated with increased mortality. The leading cause of death in this group was the CLL itself.
